Vistagen Therapeutics (VTGN) Invested Capital (2011 - 2026)
Vistagen Therapeutics' Invested Capital was $24.48 million in fiscal Q1 2027 (quarter ended Jun 30, 2026), down 57.6% from $57.7 million a year earlier and down 31.3% from the prior quarter.
Powered by 
Analysis
Vistagen Therapeutics (VTGN) Invested Capital (2011 - 2026) Analysis & Trends
For FY2026 (ended Mar 31, 2026), Invested Capital at Vistagen Therapeutics came in at $35.62 million, down 49.4% from FY2025.
- Invested Capital shows a five-year compound annual growth rate of -17.3% (FY2021 to FY2026).
- In earlier fiscal years, Invested Capital was $70.39 million in FY2025 (-38.4%), $114.29 million in FY2024 (+837.9%), $12.19 million in FY2023 (-81.2%) and $64.72 million in FY2022 (-29.6%).
- The fiscal Q1 2027 figure marks the lowest quarterly Invested Capital since fiscal Q1 2024.
- The best year-over-year quarter for Invested Capital over five years was fiscal Q4 2024 (growth of 837.9%); the worst was fiscal Q1 2024 (a decline of 83.8%).
- Per Business Quant data, VTGN's Invested Capital in the three fiscal quarters before Q1 2027 was $35.62 million (Q4 2026), $51.32 million (Q3 2026) and $67.04 million (Q2 2026).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Invested Cap. (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 134.01 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 64.89 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 95.89 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 79.44 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 50.26 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 68.99 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 38.08 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 148.69 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | - |
| 10 | Vistagen Therapeutics | 13.76 Mn | 13.76 Mn | - | 24.48 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 24.48 Mn |
| Mar 31, 2026 | 35.62 Mn |
| Dec 31, 2025 | 51.32 Mn |
| Sep 30, 2025 | 67.04 Mn |
| Jun 30, 2025 | 57.70 Mn |
| Mar 31, 2025 | 70.39 Mn |
| Mar 31, 2024 | 114.29 Mn |
| Dec 31, 2023 | 123.29 Mn |
| Sep 30, 2023 | 35.65 Mn |
| Jun 30, 2023 | 7.63 Mn |
| Mar 31, 2023 | 12.19 Mn |
| Dec 31, 2022 | 21.09 Mn |
| Sep 30, 2022 | 30.34 Mn |
| Jun 30, 2022 | 47.09 Mn |
| Mar 31, 2022 | 64.72 Mn |
| Mar 31, 2021 | 91.98 Mn |
| Dec 31, 2020 | 93.91 Mn |
| Sep 30, 2020 | 4.66 Mn |
| Jun 30, 2020 | -5.06 Mn |
| Mar 31, 2020 | -5.62 Mn |
API Access
Vistagen Therapeutics Invested Capital API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=invested-capital&ticker=VTGN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "invested-capital", "ticker": "VTGN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=invested-capital&ticker=VTGN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();